Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 1:02 PM
Ignite Modification Date: 2025-12-24 @ 1:02 PM
NCT ID: NCT04923061
Eligibility Criteria: Inclusion Criteria: Nurses who care for COVID 19 patients during the pandemic process Nurses working in internal clinics during the data collection process Those who have recovered from COVID 19 Those who agreed to participate in the study No deformity or lesions in the areas where acupressure will be applied No acupressure experience No sleep disorder diagnosis and no medical treatment Not diagnosed with anxiety disorder and not receiving medical treatment Not diagnosed with depression and not receiving medical treatment Coffee, cigarette and alcohol free No mental disorder Night shift workers Those who can understand and speak Turkish Those who signed the Informed Consent Form Exclusion Criteria: Nurses who did not work in internal clinics during the data collection process Nurses who do not care for COVID 19 patients during the pandemic process Those with active COVID 19 Those who do not agree to participate in the study Those who have any deformity or lesion in the areas where acupressure will be applied Experiences of acupressure Heart and kidney failure, severe anemia, immunodeficiency problem Pregnant Diagnosed with sleep disorder and receiving treatment Anxiety disorder and treatment Depression diagnosed and treated Coffee, cigarette and alcohol addiction Having mental illness Fixed day shift workers Those who can not understand and speak Turkish Those who did not sign the Informed Consent Form
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT04923061
Study Brief:
Protocol Section: NCT04923061